SHANGHAI, June 16, 2021 /PRNewswire/ -- Zhongchao Inc.
(NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare
services company offering online healthcare information,
professional training and educational services, today announced the
cooperation in physician education with AbbVie Pharmaceutical
Trading (Shanghai) Co., Ltd.
("AbbVie Shanghai"), a subsidiary of AbbVie Inc (NYSE: ABBV)
("AbbVie"). AbbVie is a research-based global biopharmaceutical
company. Pursuant to an agreement to facilitate such cooperation,
Zhongchao and AbbVie Shanghai will cooperate in, including but not
limited to, developing the medical education contents and producing
medical education courses.
Weiguang Yang, Chairman and Chief
Executive Officer of Zhongchao, commented, "AbbVie is one of the
top ten global research-oriented biopharmaceutical companies with
numerous innovations in the core field of immunology, oncology,
neuroscience, and Allergan Aesthetics. In recent years, AbbVie has
introduced more and more innovative therapies and drugs to the
Chinese market, benefitting Chinese patients. We are honored to
cooperate with AbbVie Shanghai to promote the development of
medical education."
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. They strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology, women's health and
gastroenterology, in addition to products and services across its
Allergan Aesthetics portfolio. For more information about AbbVie,
please visit www.abbvie.com.
About Zhongchao Inc.
Incorporated in 2012 with headquarter offices in Shanghai and Beijing, China, Zhongchao Inc. is an online
provider of healthcare information, professional training and
educational services to healthcare professionals under its "MDMOOC"
platform (www.mdmooc.org) and to the public under its
"Sunshine Health Forums" platform (www.ygjkclass.com) in
China. More information about the
Company can be found at its investor relations website at
http://izcmd.com.
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may," "will," "intend," "should," "believe," "expect,"
"anticipate," "project," "estimate" or similar expressions that do
not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
following: the Company's goals and strategies; the Company's
future business development; product and service demand and
acceptance; changes in technology; economic conditions; the growth
of the professional training and educational services market in
China and the other international
markets the Company plans to serve; reputation and brand; the
impact of competition and pricing; government regulations;
fluctuations in general economic and business conditions in
China and the international
markets the Company plans to serve and assumptions underlying or
related to any of the foregoing and other risks contained in
reports filed by the Company with the SEC, the length and severity
of the recent coronavirus outbreak, including its impacts across
our business and operations. For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, which
are available for review at www.sec.gov. The Company undertakes no
obligation to publicly revise these forward–looking statements to
reflect events or circumstances that arise after the date
hereof.
For more information, please contact:
At the Company: Pei Xu, CFO
Email: xupei@mdmooc.org
Phone: +86 21-3220-5987
Investor Relations: Sherry Zheng
Weitian Group LLC
Email: shunyu.zheng@weitian-ir.com
Phone: +1 718-213-7386
View original
content:http://www.prnewswire.com/news-releases/zhongchao-inc-partners-with-a-subsidiary-of-abbvie-inc-nyse-abbv-for-medical-education-services-301313255.html
SOURCE Zhongchao Inc.